Sloan Kettering Gets Trimmed Fees In IP Fight

By Adam Rhodes · January 2, 2018, 8:19 PM EST

A New York federal judge ordered Errant Gene Therapeutics LLC to pay the Sloan Kettering Institute for Cancer Research $88,339 in attorneys' fees Tuesday after the biopharmaceutical company was sanctioned for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015

Recent Articles By Adam

September 11, 2019
Deals Rumor Mill: WeWork, Groupon, Grab Holdings
September 10, 2019
Mallinckrodt To Sell BioVectra To HIG For Up To $250M
September 05, 2019
Bellus Health Raises $70M In Upsized Stateside IPO
September 04, 2019
VillageMD Nabs $100 Million in Kinnevik-Led Series B Round
August 30, 2019
Deals Rumor Mill: Apcoa, Blued, Smiths Group
August 26, 2019
Addus HomeCare Reaches $130M Deal For Hospice Provider
August 22, 2019
Contractor Seeks $1.3M For Work On Medical Office Project
August 21, 2019
Deals Rumor Mill: Alibaba, Goldman Sachs, Cigna
August 19, 2019
Deals Rumor Mill: Apollo Global, GoHealth, Avaya
August 16, 2019
Deals Rumor Mill: JD.com, MPI, Apollo Global